Denali Therapeutics (DNLI)
15.56
0.00 (0.00%)
Upcoming Events
Latest Headlines
Form ARS Denali Therapeutics Inc. For: Dec 31
April 18, 2024 4:07 PM - SEC Filing
Form DEFA14A Denali Therapeutics Inc.
April 18, 2024 4:04 PM - SEC Filing
Form DEF 14A Denali Therapeutics Inc. For: Dec 31
April 18, 2024 4:03 PM - SEC Filing
Form 4 Denali Therapeutics Inc. For: Apr 15 Filed by: SATO VICKI L
April 17, 2024 5:15 PM - SEC Filing
Form 144 Denali Therapeutics Inc. Filed by: SATO VICKI L
April 15, 2024 4:32 PM - SEC Filing
Denali Therapeutics Inc. (DNLI) PT Lowered to $32 at UBS
April 9, 2024 9:59 AM - StreetInsider
Flagship Appoints Amy O'Shea as CEO-Partner and Chief Executive Officer of Invaio Sciences
April 8, 2024 8:00 AM - PR NewsWire
Form 4 Denali Therapeutics Inc. For: Apr 01 Filed by: Krognes Steve E.
April 2, 2024 6:08 PM - SEC Filing
Form 144 Denali Therapeutics Inc. Filed by: Krognes Steve E.
April 1, 2024 4:36 PM - SEC Filing
Form 4 Denali Therapeutics Inc. For: Mar 29 Filed by: Watts Ryan J.
March 29, 2024 5:59 PM - SEC Filing
Denali Therapeutics (DNLI) Announces 29.29M Share Offering by Selling Stockholders
March 22, 2024 4:04 PM - StreetInsider
Form S-3ASR Denali Therapeutics Inc.
March 22, 2024 4:02 PM - SEC Filing
Form 4 Denali Therapeutics Inc. For: Mar 15 Filed by: SATO VICKI L
March 19, 2024 4:33 PM - SEC Filing
Flagship Pioneering Named to Fast Company's Annual List of the World's Most Innovative Companies of 2024
March 19, 2024 8:30 AM - PR NewsWire
Form D Denali Therapeutics Inc.
March 1, 2024 4:52 PM - SEC Filing
Denali Therapeutics Inc. (DNLI) PT Raised to $105 at H.C. Wainwright
February 29, 2024 6:37 AM - StreetInsider
Denali Therapeutics Inc. (DNLI) PT Lowered to $50 at Goldman Sachs
February 29, 2024 6:05 AM - StreetInsider
Denali Therapeutics Inc. (DNLI) PT Lowered to $36 at B.Riley
February 28, 2024 7:53 AM - StreetInsider
Form 10-K Denali Therapeutics Inc. For: Dec 31
February 28, 2024 6:27 AM - SEC Filing
Form S-8 Denali Therapeutics Inc.
February 28, 2024 6:21 AM - SEC Filing
Denali Therapeutics Inc. (DNLI) Misses Q4 EPS by 6c
February 27, 2024 9:30 AM - StreetInsider
Form 8-K Denali Therapeutics Inc. For: Feb 27
February 27, 2024 8:08 AM - SEC Filing
Denali Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights
February 27, 2024 8:05 AM - Globe NewsWire
Form 8-K Denali Therapeutics Inc. For: Feb 27
February 27, 2024 8:04 AM - SEC Filing
Denali Therapeutics (DNLI) Announces $500 million Private Placement Equity Financing
February 27, 2024 8:02 AM - StreetInsider
Denali Therapeutics Announces $500 million Private Placement Equity Financing
February 27, 2024 8:01 AM - StreetInsider
Form 4 Denali Therapeutics Inc. For: Feb 15 Filed by: SATO VICKI L
February 20, 2024 5:39 PM - SEC Filing
Form 8-K Denali Therapeutics Inc. For: Feb 16
February 16, 2024 8:03 AM - SEC Filing
Form 4 Denali Therapeutics Inc. For: Feb 13 Filed by: Krognes Steve E.
February 15, 2024 9:16 PM - SEC Filing
Form 4 Denali Therapeutics Inc. For: Feb 13 Filed by: Watts Ryan J.
February 15, 2024 9:16 PM - SEC Filing
Form 4 Denali Therapeutics Inc. For: Feb 13 Filed by: Ho Carole
February 15, 2024 9:15 PM - SEC Filing
Form 4 Denali Therapeutics Inc. For: Feb 13 Filed by: Schuth Alexander O.
February 15, 2024 9:14 PM - SEC Filing
Form 144 Denali Therapeutics Inc. Filed by: Schuth Alexander O.
February 14, 2024 4:59 PM - SEC Filing
Form 144 Denali Therapeutics Inc. Filed by: Ho Carole
February 14, 2024 4:44 PM - SEC Filing
Form 144 Denali Therapeutics Inc. Filed by: Krognes Steve E.
February 13, 2024 8:22 PM - SEC Filing
Form 144 Denali Therapeutics Inc. Filed by: Ho Carole
February 13, 2024 8:20 PM - SEC Filing
Form 144 Denali Therapeutics Inc. Filed by: Schuth Alexander O.
February 13, 2024 8:19 PM - SEC Filing
Form 144 Denali Therapeutics Inc. Filed by: Watts Ryan J.
February 13, 2024 8:18 PM - SEC Filing
Form SC 13G/A Denali Therapeutics Inc. Filed by: VANGUARD GROUP INC
February 13, 2024 5:07 PM - SEC Filing
Form SC 13G/A Denali Therapeutics Inc. Filed by: BRATTON DOUGLAS K
February 13, 2024 4:28 PM - SEC Filing
Form SC 13G/A Denali Therapeutics Inc. Filed by: BIOGEN INC.
February 12, 2024 7:08 PM - SEC Filing
Form 4 Denali Therapeutics Inc. For: Feb 08 Filed by: Schuth Alexander O.
February 12, 2024 4:49 PM - SEC Filing
Form SC 13G Denali Therapeutics Inc. Filed by: WELLINGTON MANAGEMENT GROUP LLP
February 8, 2024 10:12 AM - SEC Filing
Denali Therapeutics Announces New Data and Expansion of Its Blood-Brain Barrier (BBB)-Crossing Enzyme Replacement Therapy Programs at WORLDSymposium™
February 7, 2024 8:00 AM - StreetInsider
Denali Therapeutics Announces Presentations on Its Investigational Blood-Brain Barrier (BBB)-Crossing Enzyme Replacement Therapies at the Upcoming 2024 WORLDSymposium™
February 1, 2024 8:00 AM - StreetInsider
Form SC 13G/A Denali Therapeutics Inc. Filed by: BAILLIE GIFFORD & CO
January 30, 2024 6:59 AM - SEC Filing
Form SC 13G/A Denali Therapeutics Inc. Filed by: Temasek Holdings (Private) Ltd
January 30, 2024 6:41 AM - SEC Filing
Full Article List
